The effectiveness of reducing the daily dose of finasteride in men with benign prostatic hyperplasia

BACKGROUND: Finasteride, a 5 alpha reductase inhibitor, is an established treatment for benign prostatic hyperplasia. The recommended dosage is 5 mg a day, however case reports have show effectiveness with lower doses. The objective of the current study was to determine in men with benign prostatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Michael J, Geller, Jack
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC65043/
https://www.ncbi.nlm.nih.gov/pubmed/11818031
http://dx.doi.org/10.1186/1471-2490-2-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC65043/
https://www.ncbi.nlm.nih.gov/pubmed/11818031
http://dx.doi.org/10.1186/1471-2490-2-2

Ejemplares similares